Product name:BIBW-2992
CAS:439081-18-2
Molecular Formula:C24H25ClFN5O3
Formula Weight:485.937 g/mol
Description:BIBW-2992 is a candidate drug against non-small cell lung carcinoma.Like lapatinib and neratinib, BIBW 2992 is a next generation tyrosine kinase inhibitor (TKI) that irreversibly inhibits human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases. BIBW-2992 is not only active against EGFR mutations targeted by first generation TKIs like erlotinib or gefitinib, but also against those not sensitive to these standard therapies.